Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Secretion of wild-type factor IX upon readthrough over F9 pre-peptide nonsense mutations causing hemophilia B.

Ferrarese M, Testa MF, Balestra D, Bernardi F, Pinotti M, Branchini A.

Hum Mutat. 2018 Feb 1. doi: 10.1002/humu.23404. [Epub ahead of print]

PMID:
29388273
2.

Clustered F8 missense mutations cause hemophilia A by combined alteration of splicing and protein biosynthesis and activity.

Donadon I, McVey JH, Garagiola I, Branchini A, Mortarino M, Peyvandi F, Bernardi F, Pinotti M.

Haematologica. 2018 Feb;103(2):344-350. doi: 10.3324/haematol.2017.178327. Epub 2017 Nov 23.

3.

Specific factor IX mRNA and protein features favor drug-induced readthrough over recurrent nonsense mutations.

Branchini A, Ferrarese M, Campioni M, Castaman G, Mari R, Bernardi F, Pinotti M.

Blood. 2017 Apr 20;129(16):2303-2307. doi: 10.1182/blood-2016-09-738641. Epub 2017 Feb 14.

4.

Differential functional readthrough over homozygous nonsense mutations contributes to the bleeding phenotype in coagulation factor VII deficiency.

Branchini A, Ferrarese M, Lombardi S, Mari R, Bernardi F, Pinotti M.

J Thromb Haemost. 2016 Oct;14(10):1994-2000. doi: 10.1111/jth.13443. Epub 2016 Sep 19.

PMID:
27513915
5.

An engineered tale-transcription factor rescues transcription of factor VII impaired by promoter mutations and enhances its endogenous expression in hepatocytes.

Barbon E, Pignani S, Branchini A, Bernardi F, Pinotti M, Bovolenta M.

Sci Rep. 2016 Jun 24;6:28304. doi: 10.1038/srep28304.

6.

Activated factor VII-antithrombin complex predicts mortality in patients with stable coronary artery disease: a cohort study.

Martinelli N, Girelli D, Baroni M, Guarini P, Sandri M, Lunghi B, Tosi F, Branchini A, Sartori F, Woodhams B, Bernardi F, Olivieri O.

J Thromb Haemost. 2016 Apr;14(4):655-66. doi: 10.1111/jth.13274. Epub 2016 Mar 14.

PMID:
27061056
7.

Impact of a Probiotic-Based Cleaning Intervention on the Microbiota Ecosystem of the Hospital Surfaces: Focus on the Resistome Remodulation.

Caselli E, D'Accolti M, Vandini A, Lanzoni L, Camerada MT, Coccagna M, Branchini A, Antonioli P, Balboni PG, Di Luca D, Mazzacane S.

PLoS One. 2016 Feb 17;11(2):e0148857. doi: 10.1371/journal.pone.0148857. eCollection 2016.

8.

The carboxyl-terminal region is NOT essential for secreted and functional levels of coagulation factor X.

Branchini A, Baroni M, Burini F, Puzzo F, Nicolosi F, Mari R, Gemmati D, Bernardi F, Pinotti M.

J Thromb Haemost. 2015 Aug;13(8):1468-74. doi: 10.1111/jth.13034. Epub 2015 Jul 14.

9.

Asymmetric processing of mutant factor X Arg386Cys reveals differences between intrinsic and extrinsic pathway activation.

Baroni M, Pavani G, Pinotti M, Branchini A, Bernardi F, Camire RM.

Biochim Biophys Acta. 2015 Oct;1854(10 Pt A):1351-6. doi: 10.1016/j.bbapap.2015.05.012. Epub 2015 May 23.

PMID:
26012870
10.

Hard surface biocontrol in hospitals using microbial-based cleaning products.

Vandini A, Temmerman R, Frabetti A, Caselli E, Antonioli P, Balboni PG, Platano D, Branchini A, Mazzacane S.

PLoS One. 2014 Sep 26;9(9):e108598. doi: 10.1371/journal.pone.0108598. eCollection 2014.

11.

Coagulation factor VII variants resistant to inhibitory antibodies.

Branchini A, Baroni M, Pfeiffer C, Batorova A, Giansily-Blaizot M, Schved JF, Mariani G, Bernardi F, Pinotti M.

Thromb Haemost. 2014 Nov;112(5):972-80. doi: 10.1160/TH14-03-0198. Epub 2014 Aug 7.

PMID:
25104096
12.

Factor II activity is similarly increased in patients with elevated apolipoprotein CIII and in carriers of the factor II 20210A allele.

Olivieri O, Martinelli N, Baroni M, Branchini A, Girelli D, Friso S, Pizzolo F, Bernardi F.

J Am Heart Assoc. 2013 Nov 15;2(6):e000440. doi: 10.1161/JAHA.113.000440.

13.

Replacement of the Y450 (c234) phenyl ring in the carboxyl-terminal region of coagulation factor IX causes pleiotropic effects on secretion and enzyme activity.

Branchini A, Campioni M, Mazzucconi MG, Biondo F, Mari R, Bicocchi MP, Bernardi F, Pinotti M.

FEBS Lett. 2013 Oct 1;587(19):3249-53. doi: 10.1016/j.febslet.2013.08.019. Epub 2013 Aug 27.

14.

Activation of a cryptic splice site in a potentially lethal coagulation defect accounts for a functional protein variant.

Cavallari N, Balestra D, Branchini A, Maestri I, Chuamsunrit A, Sasanakul W, Mariani G, Pagani F, Bernardi F, Pinotti M.

Biochim Biophys Acta. 2012 Jul;1822(7):1109-13. doi: 10.1016/j.bbadis.2012.03.001. Epub 2012 Mar 9.

15.

Characteristics of pioneers of nursing informatics: a thematic analysis.

Branchini AZ, Brixey JJ, Polifroni EC.

NI 2012 (2012). 2012 Jun 23;2012:46. eCollection 2012.

16.

Natural and engineered carboxy-terminal variants: decreased secretion and gain-of-function result in asymptomatic coagulation factor VII deficiency.

Branchini A, Rizzotto L, Mariani G, Napolitano M, Lapecorella M, Giansily-Blaizot M, Mari R, Canella A, Pinotti M, Bernardi F.

Haematologica. 2012 May;97(5):705-9. doi: 10.3324/haematol.2011.049403. Epub 2011 Dec 16.

17.

Chronic sleep deprivation markedly reduces coagulation factor VII expression.

Pinotti M, Bertolucci C, Frigato E, Branchini A, Cavallari N, Baba K, Contreras-Alcantara S, Ehlen JC, Bernardi F, Paul KN, Tosini G.

Haematologica. 2010 Aug;95(8):1429-32. doi: 10.3324/haematol.2010.022475. Epub 2010 Apr 23.

18.

Characterization of the intracellular signalling capacity of natural FXa mutants with reduced pro-coagulant activity.

Monti M, Borensztajn KS, Pinotti M, Canella A, Branchini A, Marchetti G, Reitsma PH, Bernardi F, Spek CA.

Thromb Res. 2009 Apr;123(6):914-8. doi: 10.1016/j.thromres.2008.10.012. Epub 2008 Dec 23.

PMID:
19108874

Supplemental Content

Loading ...
Support Center